History of the Transplant Institute
30 Years of Organ Transplant Surgery Experience and Expertise in Dallas, Texas
Throughout its history, The Transplant Institute at Methodist Dallas has
maintained a commitment to innovation in transplant medicine. Since the
first organ transplant at Methodist Dallas more than 30 years ago, independently
practicing physicians on the medical staff have regularly participated
in research that helps advance transplant medicine and dramatically increases
organ transplant surgery success rates.
2013
Methodist's
First Paired Donor Exchange Transplant
Methodist's first Altruistic donor
2011
The Methodist Transplant Program celebrates the 30th anniversary of kidney
transplant services.
The Liver Institute announces its involvement in several clinical trials
using a newer generation of drugs for the treatment of chronic hepatitis
C. The trials will focus on a second generation of direct-acting antiviral
drugs for hepatitis C that are very potent and may shorten the duration
of therapy in a number of patients. These antiviral drugs offer very promising
hope for eradication of hepatitis C for patients who have experienced
and failed treatment in the past.
2009
Methodist Dallas Transplant Institute celebrates patient number 2,700.
Methodist Dallas Transplant Institute becomes the first in the Dallas–Fort
Worth Metroplex to perform a kidney transplant on an HIV-positive patient.
2008
New antibody-lowering therapy for kidney transplants is introduced.
2007
HIV-positive kidney transplant protocol is added.
2004
Two patients are successfully treated using an antibody-lowering protocol
for the highly sensitized patient.
Paired exchange is offered to patients on Methodist Dallas Transplant Institute’s
kidney transplant waiting list, matching a recipient-donor pair –
with incompatible blood or tissue types – with another recipient-donor pair.
2003
The Transplant Institute at Methodist Dallas expands its service with the
opening of
The Liver Institute at Methodist Dallas — one of only three facilities in the Dallas–Fort Worth, Texas
area that performs adult liver transplants.
In addition to performing liver transplants, The Liver Institute at Methodist
Dallas offers comprehensive, and multidisciplinary care for liver disease,
including:
- Hepatitis
- Hepatology program
- Liver tumor program
- Clinic for hepatobiliary and pancreatic disorders
1999
Texas’ first successful living donor laparoscopic nephrectomy is
performed at The Transplant Institute at Methodist Dallas. Since then
almost 300 laparoscopic donor nephrectomies have been performed at The Transplant
Institute at Methodist Dallas.
1992
Independently practicing physicians on the Methodist Health System medical
staff make worldwide history by successfully performing the
world's first simultaneous heart-kidney-pancreas transplant at Methodist Dallas Medical Center.
1986
The first pancreas transplant in Dallas–Fort Worth is performed at
Methodist Dallas.
The first heart transplant at The Transplant Institute at Methodist Dallas
is performed, furthering the hospital’s reputation as a center for
comprehensive, sophisticated cardiac care and leadership in transplant medicine.
1983
The first kidney transplant for a Puerto Rican patient – the 100th
transplant overall – is performed. To date, more than 325 kidney
transplants have been performed on Puerto Rican patients. There are more
than 100 patients from Puerto Rico on The Transplant Institute at Methodist
Dallas's waiting list. The Transplant Institute operates two offices in
Puerto Rico.
1981
The Transplant Institute at Methodist Dallas’s commitment to the
Latin community begins with its first kidney transplant for a patient
from Ecuador.
1980
Methodist Dallas Medical Center establishes a kidney transplant program
as part of a long-standing commitment to comprehensive care for people
with end-stage renal disease.
The success of this program leads to others such as pancreas transplants
and combined kidney-pancreas transplants. Methodist Dallas is the first
private hospital in Texas to offer this promising alternative treatment
for diabetes.